Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying



Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABMD — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree ABMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ABMD — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the ABIOMED Insider Buying occurred are:

G and K Services Insider Buying
ShoreTel Insider Buying
Otonomy Insider Buying
Skystar Bio-Pharmaceutical Insider Buying
Precision Castparts Insider Buying
Cadence Design Systems Insider Buying
QLogic Insider Buying
Oncothyreon Insider Buying
Bi-Optic Ventures Insider Buying
Community Bank Shares of Indiana Insider Buying

ABIOMED insider buying image
The table below summarizes the most recent ABIOMED insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ABIOMED insider buys are important for investors to follow.
DateInsiderPriceAmount
5-29-2015
Insider Buy		 Martin P. Sutter
Director		 $60.17
CAGR » 		$451,275.00
7,500 shares
5-7-2013
Insider Buy		 Henri A. Termeer
Director		 $19.86
CAGR » 		$1,986,410.00
100,000 shares
2-25-2013
Insider Buy		 Henri A. Termeer
Director		 $14.98
CAGR » 		$1,497,793.77
100,000 shares

Also See: Institutional Holders of ABMD
Also See: SEC filings

ABMD Performance Since Insider Purchase
Below we present the annualized performance delivered by ABIOMED stock since 5-29-2015 (the date of the most recent insider purchase). The performance of the investment from the time ABIOMED insider buying occurred is the ultimate test of whether insiders were right about ABMD being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 06/01/2015
End date: 12/22/2022
Start price/share: $60.34
End price/share: $381.02
Dividends collected/share: $0.00
Total return: 531.46%
Average Annual Total Return: 27.59%
Starting investment: $10,000.00
Ending investment: $63,159.35
Years: 7.56

ABIOMED Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ABIOMED insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ABMD

ABIOMED Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.